JB Capital LLC Buys 178 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

JB Capital LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 7,143 shares of the healthcare conglomerate’s stock after purchasing an additional 178 shares during the period. JB Capital LLC’s holdings in UnitedHealth Group were worth $4,176,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. China Universal Asset Management Co. Ltd. raised its holdings in UnitedHealth Group by 20.6% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after acquiring an additional 1,857 shares in the last quarter. Quent Capital LLC lifted its position in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares during the period. MGB Wealth Management LLC increased its holdings in UnitedHealth Group by 0.7% in the 1st quarter. MGB Wealth Management LLC now owns 3,937 shares of the healthcare conglomerate’s stock valued at $1,947,000 after buying an additional 29 shares during the period. Concord Investment Counsel Inc. acquired a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $14,544,000. Finally, Duality Advisers LP acquired a new position in UnitedHealth Group during the first quarter valued at approximately $4,602,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on UNH. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Truist Financial reissued a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Barclays lowered their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $615.53.

Get Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Up 0.8 %

NYSE UNH traded up $4.78 on Thursday, hitting $601.47. 542,426 shares of the company were exchanged, compared to its average volume of 3,884,471. The stock has a fifty day moving average of $581.13 and a 200-day moving average of $543.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a market cap of $555.41 billion, a PE ratio of 38.87, a PEG ratio of 1.64 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the firm posted $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.